Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that may lead to a more condensed chromatin state around the OR5D13 gene locus, potentially reducing accessibility of the transcriptional machinery and thus downregulating OR5D13 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could decrease DNA methylation levels at the promoter of OR5D13, which might result in a silenced gene state by attracting methyl-binding domain proteins that recruit co-repressor complexes to the OR5D13 locus. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 suppresses histone deacetylase activity, which could lead to a decrease in transcriptional activity of the OR5D13 gene by promoting a chromatin structure that is less permissive for transcription factor binding and gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, by inhibiting histone deacetylase enzymes, may cause histone hyperacetylation at the OR5D13 site, resulting in chromatin remodeling that could lead to transcriptional repression of the OR5D13 gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds specifically to GC-rich DNA sequences, which could block the binding sites for essential transcription factors at the OR5D13 promoter, thereby inhibiting the initiation of its transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine is known to inhibit DNA methyltransferase, which might lead to a reduction in methylation at the OR5D13 promoter region, potentially triggering the recruitment of repressor proteins that silence gene expression. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
Hydralazine may lead to DNA demethylation, which could contribute to a downregulation of OR5D13 by creating an unsuitable epigenetic environment for the expression of this gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could act as a ligand for nuclear receptors that bind to retinoic acid response elements (RARE) in gene promoters, which might include the OR5D13 promoter, leading to a decrease in OR5D13 expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, by reducing folate, could indirectly lead to a decrease in the methylation capacity of the cell, potentially resulting in the downregulation of OR5D13 expression due to altered epigenetic states. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit DNA methyltransferase, potentially decreasing the methylation status of the OR5D13 gene region and leading to the recruitment of transcriptional repressors that inhibit the gene′s expression. | ||||||